Cite
MLA Citation
M.R. Savona et al.. “Randomized Phase 2 Study of Guadecitabine in Patients with HMA-Naive Higher Risk Myelodysplastic Syndromes (MDS) or Chronic Myelomonocytic Leukemia (CMML).” Leukemia research, vol. 55, n.d., pp. S40–S41. http://access.bl.uk/ark:/81055/vdc_100045920464.0x00003a